市场调查报告书
商品编码
1210967
瘙痒症(瘙痒症)药物的全球市场研究和预测:按药物类型、疾病类型、分销渠道和地区分析,2022-2029Global Pruritus Therapeutics Market Size study & Forecast, by Drug Type, by Disease Type, by Distribution Channel and Regional Analysis, 2022-2029 |
2021 年全球瘙痒症治疗市场价值约为 79 亿美元,预计在 2022-2029 年预测期内将以超过 3.6% 的健康增长率增长。
瘙痒症是皮肤发痒的医学术语。 许多皮肤瘙痒状况与皮肤干燥、过敏和潜在的皮肤状况有关。 此外,某些形式的皮肤瘙痒症与多种疾病有关,例如癌症、糖尿病、HIV 以及肝胆疾病。 这种情况可以用口服药物治疗。 全球皮肤病患病率的上升、电子药房增长的出现以及主要市场参与者的战略举措是加速市场增长的关键因素。
特应性皮炎、过敏性接触性皮炎和荨麻疹等皮肤病发病率的增加促进了全球瘙痒症市场的增长。 例如,根据国家生物技术信息中心 (NCBI) 的数据,截至 2019 年,接触性过敏影响了欧洲约 20% 的总人口。 此外,根据世界过敏组织的数据——截至 2020 年,全球范围内,接触性皮炎约占发达国家所有职业性皮肤病的 85-95%,每年约有 570 万人次就诊。据说 此外,预计新兴市场医疗基础设施的发展和老年人口的增加将为预测期内的市场创造良好的增长前景。 然而,缺乏对潜在疾病的认识阻碍了整个 2022-2029 年预测期内的市场增长。
全球瘙痒症治疗市场研究中考虑的主要区域是亚太地区、北美、欧洲、拉丁美洲和世界其他地区。 由于皮肤病的流行和大型製药公司的存在,北美已成为市场份额的主要地区。 另一方面,由于老年人口增加和製药行业扩张等因素,预计亚太地区在预测期内将以最高复合年增长率增长。
这项研究的目的是揭示近年来各个细分市场和国家/地区的市场规模,并预测未来几年的市场规模。 该报告旨在捕捉被调查国家工业的定性和定量方面的情况。
它还提供了关键方面的详细信息,例如决定市场未来增长的驱动因素和挑战。 此外,它还包含供利益相关者投资的微观市场潜在机会,以及对主要参与者的竞争格局和产品供应的深入分析。
按药物类型
皮质类固醇
抗组胺药
局部麻醉剂
免疫抑製剂
杂项
按疾病
特应性皮炎
过敏性接触性皮炎
荨麻疹
杂项
按销售渠道
医院药房
药店/零售商
在线提供商
Global Pruritus Therapeutics Market is valued at approximately USD 7.9 billion in 2021 and is anticipated to grow with a healthy growth rate of more than 3.6% over the forecast period 2022-2029. Pruritus is a medical term for itchy skin. Most of the itchy skin conditions are associated with Dry skin, allergies, and underlying Skin disease. Moreover, certain types of pruritus are associated with various diseases including cancer, diabetes, HIV, liver & gallbladder diseases among others. This condition can be treated using oral treatments. The increasing prevalence of skin diseases worldwide and growing emergence of e-pharmacy as well as strategic initiatives from leading market players are key factors accelerating the market growth.
The increasing incidences of skin disorders such as Atopic Dermatitis, Allergic Contact Dermatitis, Urticaria are contributing to the growth of the Global Pruritus Market. For instance, according to the National Center for Biotechnology Information (NCBI) - as of 2019, in Europe about 20% of the general population is affected by contact allergies. Moreover, as per World Allergy Organization - as of 2020, globally contact dermatitis accounts for approximately 85 - 95% of all occupational skin diseases in industrialized countries and contributes to an estimated 5.7 million physician visits per year. Also, growing healthcare infrastructure in developing regions and rising number of geriatric individuals would create a lucrative growth prospectus for the market over the forecast period. However, lack of awareness towards underlying disease stifles market growth throughout the forecast period of 2022-2029.
The key regions considered for the Global Pruritus Therapeutics Market study include Asia Pacific, North America, Europe, Latin America, and Rest of the World. North America is the leading region in terms of market share owing to growing prevalence of skin disorders as well as presence of leading pharmaceutical companies in the region. Whereas Asia Pacific is expected to grow with the highest CAGR during the forecast period, owing to factors such as rising geriatric population and rising expansion of pharmaceutical sector in the region.
Major market players included in this report are:
AbbVie Inc.
Amgen Inc.
Bausch Health Companies Inc.
Cara therapeutics, Inc.
Cipla Ltd.
Eilly Lilly and company
Evelo Biosciences
Galderma S.A.
LEO Pharma
MC2 therapeuitics
Recent Developments in the Market:
Global Pruritus Therapeutics Market Report Scope:
Historical Data: 2019-2020-2021
Base Year for Estimation: 2021
Forecast period: 2022-2029
Report Coverage: Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends
Segments Covered: Drug Type, Disease Type, Distribution Channel, Region
Regional Scope: North America; Europe; Asia Pacific; Latin America; Rest of the World
Customization Scope: Free report customization (equivalent up to 8 analyst's working hours) with purchase. Addition or alteration to country, regional & segment scope*
The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.
The report also caters detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:
By Drug Type
Corticosteroids
Antihistamines
Local Anesthetics
Immunosuppressant
Others
By Disease Type
Atopic Dermatitis
Allergic Contact Dermatitis
Urticaria
Others
By Distribution Channel
Hospital Pharmacies
Drug stores & Retail Pharmacies
Online providers
By Region:
North America
U.S.
Canada
Europe
UK
Germany
France
Spain
Italy
ROE
Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC
Latin America
Brazil
Mexico
RoLA
Rest of the World
List of tables and figures and dummy in nature, final lists may vary in the final deliverable
List of figures
List of tables and figures and dummy in nature, final lists may vary in the final deliverable